[HTML][HTML] Emerging role of tumor cell plasticity in modifying therapeutic response

S Qin, J Jiang, Y Lu, EC Nice, C Huang… - Signal transduction and …, 2020 - nature.com
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …

Cell spheroids: the new frontiers in in vitro models for cancer drug validation

M Chatzinikolaidou - Drug discovery today, 2016 - Elsevier
Highlights•Characteristics of the tumor microenvironment that have to be considered for the
development of 3D cell spheroid model systems for translational cancer research.•Methods …

[HTML][HTML] Therapeutic approaches targeting cancer stem cells

Y Pan, S Ma, K Cao, S Zhou, A Zhao, M Li… - Journal of cancer …, 2018 - journals.lww.com
Increasing studies have demonstrated that most tumors consisted a subpopulation of cells
with stem cell properties, known as cancer stem cells (CSCs). Accumulating evidence …

Medulloblastoma: Molecular understanding, treatment evolution, and new developments

X Liu, C Ding, W Tan, A Zhang - Pharmacology & therapeutics, 2020 - Elsevier
Medulloblastoma (MB) is the most common childhood malignant brain tumor, accounting for
approximately 20% of all pediatric central nervous system tumors. Current standard …

[HTML][HTML] Dual or multiple drug loaded nanoparticles to target breast cancer stem cells

Y Gao, M Tang, E Leung, D Svirskis, A Shelling, Z Wu - RSC advances, 2020 - pubs.rsc.org
Breast cancer stem (-like) cells (BCSCs) have been found to be responsible for therapeutic
resistance and disease relapse. BCSCs are difficult to eradicate due to their high resistance …

Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61

A Calcaterra, V Iovine, B Botta, D Quaglio… - Journal of enzyme …, 2018 - Taylor & Francis
This work aims at elucidating the mechanism and kinetics of hydrolysis of GANT61, the first
and most-widely used inhibitor of the Hedgehog (Hh) signalling pathway that targets Glioma …

[HTML][HTML] Potential of steroidal alkaloids in cancer: perspective insight into structure–activity relationships

Y Huang, G Li, C Hong, X Zheng, H Yu… - Frontiers in …, 2021 - frontiersin.org
Steroidal alkaloids contain both steroidal and alkaloid properties in terms of chemical
properties and pharmacological activities. Due to outstanding biological activities such as …

[HTML][HTML] Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia

M Mori, L Tottone, D Quaglio, N Zhdanovskaya… - Scientific Reports, 2017 - nature.com
Notch signaling is considered a rational target in the therapy of several cancers, particularly
those harbouring Notch gain of function mutations, including T-cell acute lymphoblastic …

Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold

S Berardozzi, F Bernardi, P Infante, C Ingallina… - European Journal of …, 2018 - Elsevier
Aberrant activation of the Hedgehog (Hh) pathway is responsible for the onset and
progression of several malignancies. Small molecules able to block the pathway at the …

Current trends in Hedgehog signaling pathway inhibition by small molecules

F Ghirga, M Mori, P Infante - Bioorganic & Medicinal Chemistry Letters, 2018 - Elsevier
Abstract The Hedgehog (Hh) signaling pathway is a widely appreciated target for anticancer
therapy. However, drug resistance at the Smoothened receptor (SMO) and Hh activation …